HOCHDOSIERTES METHYLPREDNISOLON ALS ANTIEMETIKUM BEIM ZYTOSTATIKA-BEDINGTEN ERBRECHEN

Translated title of the contribution: High-dose methylprednisolone in vomiting due to cytostatic treatment

R. Joss, A. Gervasi, A. Goldhirsch, K. W. Brunner

Research output: Contribution to journalArticle

Abstract

The antiemetic efficacy of 375 mg methylprednisolone given as slow i.v. push injection was assessed in 27 tumor patients receiving strongly emetic cytostatic treatment. 13 of 27 patients were partially or completely protected from nausea and vomiting. Only minor side effects from methylprednisolone were observed: two patients complained of increased fatigue and four patients experienced facial rash with swelling 1 to 24 hours after the injection of methylprednisolone. High-dose methylprednisolone is an effective antiemetic treatment for patients receiving cancer chemotherapy.

Translated title of the contributionHigh-dose methylprednisolone in vomiting due to cytostatic treatment
Original languageGerman
Pages (from-to)426-429
Number of pages4
JournalSchweizerische Medizinische Wochenschrift
Volume113
Issue number12
Publication statusPublished - 1983

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'High-dose methylprednisolone in vomiting due to cytostatic treatment'. Together they form a unique fingerprint.

  • Cite this